J Mark Sloan

Author PubWeight™ 13.01^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.	Blood	2011	2.72
2	Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center.	JAMA Intern Med	2013	2.52
3	Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial.	Haematologica	2012	1.00
4	Iron-Deficiency Anemia.	N Engl J Med	2015	0.97
5	Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with amyloid deposition: a clinicopathologic case series.	Am J Clin Pathol	2012	0.97
6	High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center.	Blood	2012	0.95
7	A forgotten cause of kidney injury in chronic myelomonocytic leukemia.	Am J Kidney Dis	2009	0.89
8	Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study.	Haematologica	2011	0.85
9	Oral cyclic melphalan and dexamethasone for patients with AL amyloidosis.	Clin Lymphoma Myeloma Leuk	2010	0.83
10	Multiple arterial and venous thromboembolic complications in AL amyloidosis and cardiac involvement: a case report and literature review.	Amyloid	2012	0.77
11	Antineutrophil cytoplasmic antibodies, autoimmune neutropenia, and vasculitis.	Semin Arthritis Rheum	2011	0.75
12	Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosis.	Amyloid	2014	0.75
13	Successful long-term management of aneurysm-associated chronic disseminated intravascular coagulation with low molecular weight heparin.	J Card Surg	2012	0.75